Skip to main content

Table 5 AMH cut off (3.32 ng/mL) analyzed concomitantly with other ORM in parallel and in series, the prediction of amenorrhea or oligomenorrhea

From: Age, anti-müllerian hormone, antral follicles count to predict amenorrhea or oligomenorrhea after chemotherapy with cyclophosphamide

Age ≥ 32 years

Parallel test

Series test

 

Sensivity

Specificity

Sensivity

Specificity

AMH ≤3,32

99,4 %

26 %

81 %

80 %

AFC <13 follicles

99 %

24 %

78 %

78 %